TABLE 5.
Absorbance values from an ELISA after binding of purified human anti-gG-1 antibodies to GMK cells infected with different HSV strainsa
Isolate or strain | Mean absorbance ± SD
|
||||
---|---|---|---|---|---|
Patient 1 serum | Patient 5 serum | Patient 7 serum | Patient 9 serum | Anti-gB MAb | |
2 | 0.40 ± 0.03 | 0.49 ± 0.01 | 0.16 ± 0.01 | 0.23 ± 0.01 | 2.4 ± 0.10 |
5 | 0.27 ± 0.01 | 0.44 ± 0.04 | 0.13 ± 0.01 | 0.18 ± 0.01 | 2.2 ± 0.20 |
7 | 0.14 ± 0.01 | 0.40 ± 0.01 | 0.14 ± 0.01 | 0.19 ± 0.01 | 1.9 ± 0.20 |
9 | 0.40 ± 0.01 | 0.45 ± 0.01 | 0.15 ± 0.01 | 0.19 ± 0.01 | 2.3 ± 0.10 |
KOS 321 | 0.14 ± 0.01 | 0.40 ± 0.02 | 0.12 ± 0.01 | 0.15 ± 0.01 | 2.0 ± 0.20 |
Syn 17+ | 0.44 ± 0.01 | 0.52 ± 0.01 | 0.14 ± 0.01 | 0.22 ± 0.01 | 2.8 ± 0.10 |
F | 0.52 ± 0.12 | 0.54 ± 0.05 | 0.13 ± 0.01 | 0.19 ± 0.01 | 2.1 ± 0.30 |
Uninfected cells | 0.10 ± 0.01 | 0.10 ± 0.01 | 0.10 ± 0.01 | 0.10 ± 0.01 | 0.10 ± 0.02 |
A MAb reactive with gB was used as a positive control.